Netherton syndrome associated with growth hormone deficiency

Pediatric Dermatology

Volumn 31, Issue 1, 2014, Pages 90-94

  Aydin, Banu Küçükemre ^a   Baş, Firdevs ^a   Tamay, Zeynep ^a   Kiliç, Gürkan ^a   Süleyman, Ayşe ^a   Bundak, Rüveyde ^a   Saka, Nurçin ^a   Özkaya, Esen ^a   Güler, Nermin ^a   Darendeliler, Feyza ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN;

ARTICLE; ATOPIC DERMATITIS; BODY HEIGHT; BONE AGE; CASE REPORT; CHILD; DNA DETERMINATION; DNA SEQUENCE; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; GESTATIONAL AGE; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONAL THERAPY; HUMAN; ICHTHYOSIS; MALE; MEDICAL HISTORY; MICROSCOPY; MONOZYGOTIC TWINS; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NETHERTON DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROVOCATION TEST; SCALP HAIR; SCANTY HAIR; SCHOOL CHILD; SHORT STATURE; SKIN DEFECT; SKIN REDNESS; TRICHORRHEXIS;

CHILD; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; NETHERTON SYNDROME; PROTEINASE INHIBITORY PROTEINS, SECRETORY; TREATMENT OUTCOME; TWINS;

EID: 84891848580     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/pde.12220     Document Type: Article

References (14)

1. Smith DL, Smith JG, Wong SW, et al. Netherton's syndrome: A syndrome of elevated IgE and characteristic skin and hair findings. J Allergy Clin Immunol 1995; 95: 116-123.
2. Chavanas S, Garner C, Bodemer C, et al. Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. Am J Human Genet 2000; 66: 914-921.
3. Chavanas S, Bodemer C, Rochat A, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-142.
4. Kilic G, Guler N, Ones U, et al. Netherton syndrome: report of identical twins presenting severe atopic dermatitis. Eur J Pediatr 2006; 165: 594-597.
5. Bereket A,. Diagnosis of growth hormone deficiency: the role of growth hormone (GH), insulin like growth factor (IGF-I) and IGF-binding protein (IGFBP-3). J Clin Res Ped Endo 2009; 1 (Suppl 1): 23-35.
6. de Berker DA, Paige DG, Ferguson DJ, et al. Golf tee hairs in Netherton disease. Pediatr Dermatol 1995; 12: 7-11.
7. Elias PM, Schmuth M,. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep 2009; 9: 265-272.
8. Komatsu N, Saijoh K, Otsuki N, et al. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-type5 (SPINK5) protein. Clin Chim Acta 2007; 377: 228-236.
9. Jones TH, Figueroa CD, Smith C, et al. Characterization of a tissue kallikrein in human prolactin-secreting adenomas. J Endocrinol 1989; 124: 327-331.
10. Jones TH, Figueroa CD, Smith CM, et al. Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas. J Endocrinol 1992; 134: 149-154.
11. Falabela AS, Falanga V,. Wound healing. In:, Freinkel RK, Woodley DT, eds. The biology of the skin. Pearl River, NY: Parthenon, 2001: 281-297.
12. Põvoa G, Diniz LM,. Growth hormone system: skin interactions. An Bras Dermatol 2011; 86: 1159-1165.
13. Borlu M, Tanriverdi F, Koc CA, et al. The effects of severe growth hormone deficiency on the skin of patients with Sheehan's syndrome. J Eur Acad Dermatol Venereol 2007; 21: 199-204.
14. Lobie PE, Breipohl W, Lincoln DT, et al. Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 1990; 126: 467-471.